Effect of oral resveratrol on the BDNF gene expression in the hippocampus of the rat brain

Neurochemical Research

Volumn 36, Issue 5, 2011, Pages 761-765

  Rahvar, Mostafa ^a   Nikseresht, Mohsen ^b   Shafiee, Sayed Mohammad ^a   Naghibalhossaini, Fakhraddin ^a   Rasti, Mozhgan ^a   Panjehshahin, Mohammad Reza ^c   Owji, Ali Akbar ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b YASUJ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

BDNF; Hippocampus; Rat; Resveratrol

Indexed keywords

MESSENGER RNA; RESVERATROL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BDNF GENE; CONTROLLED STUDY; DOSE RESPONSE; DRUG MECHANISM; GENE; GENE EXPRESSION; HIPPOCAMPUS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION;

ADMINISTRATION, ORAL; ANIMALS; ANTIOXIDANTS; BASE SEQUENCE; BRAIN-DERIVED NEUROTROPHIC FACTOR; DNA PRIMERS; GENE EXPRESSION; HIPPOCAMPUS; MALE; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STILBENES;

RATTUS;

EID: 79954443455     PISSN: 03643190     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11064-010-0396-8     Document Type: Article

References (31)

1. KB Harikumar BB Aggarwal 2008 Resveratrol: a multitargeted agent for age-associated chronic diseases Cell Cycle 7 1020 1035 18414053 10.4161/cc.7.8.5740 1:CAS:528:DC%2BD1cXnvVSrsLY%3D
2. M Mokni S Elkahoui F Limam M Amri E Aouani 2007 Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat Neurochem Res 32 981 987 17401679 10.1007/s11064-006-9255-z 1:CAS:528:DC%2BD2sXltVWntLg%3D (Pubitemid 46726017)
3. YS Han S Bastianetto Y Dumont R Quirion 2006 Specific plasma membrane binding sites for polyphenols, including resveratrol, in the rat brain J Pharmacol Exp Ther 318 238 245 16574779 10.1124/jpet.106.102319 1:CAS:528:DC%2BD28XmsFymtrg%3D
4. M Pallas G Casadesus MA Smith A Coto-Montes C Pelegri J Vilaplana A Camins 2009 Resveratrol and neurodegenerative diseases: activation of sirt1 as the potential pathway towards neuroprotection Curr Neurovasc Res 6 70 81 19355928 10.2174/156720209787466019 1:CAS:528:DC%2BC3cXislyjtrs%3D
5. F Zhang J Liu JS Shi 2010 Anti-inflammatory activities of resveratrol in the brain: role of resveratrol in microglial activation Eur J Pharmacol 636 1 7 20361959 10.1016/j.ejphar.2010.03.043 1:CAS:528:DC%2BC3cXlvVaqurs%3D
6. S Cohen-Cory AH Kidane NJ Shirkey S Marshak 2010 Brain-derived neurotrophic factor and the development of structural neuronal connectivity Dev Neurobiol 70 271 288 20186709 1:CAS:528:DC%2BC3cXlvVKisb0%3D
7. T Numakawa S Suzuki E Kumamaru N Adachi M Richards H Kunugi 2010 Bdnf function and intracellular signaling in neurons Histol Histopathol 25 237 258 20017110 1:CAS:528:DC%2BC3cXislamt70%3D
8. WJ Tyler LD Pozzo-Miller 2001 Bdnf enhances quantal neurotransmitter release and increases the number of docked vesicles at the active zones of hippocampal excitatory synapses J Neurosci 21 4249 4258 11404410 1:CAS:528:DC%2BD3MXktlKls7k%3D (Pubitemid 32538550)
9. MC Pardon 2010 Role of neurotrophic factors in behavioral processes: implications for the treatment of psychiatric and neurodegenerative disorders Vitam Horm 82 185 200 20472139 10.1016/S0083-6729(10)82010-2 1:CAS:528:DC%2BC3cXhtVajtrvM
10. S Pezet M Malcangio 2004 Brain-derived neurotrophic factor as a drug target for cns disorders Expert Opin Ther Targets 8 391 399 15469390 10.1517/14728222.8.5.391 1:CAS:528:DC%2BD2cXotFKhtLY%3D (Pubitemid 39359646)
11. K Takuma A Matsuo Y Himeno Y Hoshina Y Ohno Y Funatsu S Arai H Kamei H Mizoguchi T Nagai K Koike M Inoue K Yamada 2007 17beta-estradiol attenuates hippocampal neuronal loss and cognitive dysfunction induced by chronic restraint stress in ovariectomized rats Neuroscience 146 60 68 17320294 10.1016/j.neuroscience.2007.01.017 1:CAS:528:DC%2BD2sXkslaisLc%3D (Pubitemid 46654620)
12. J Zou F Crews 2006 Creb and nf-kappab transcription factors regulate sensitivity to excitotoxic and oxidative stress induced neuronal cell death Cell Mol Neurobiol 26 385 405 16633891 10.1007/s10571-006-9045-9 1:CAS:528:DC%2BD28Xhtleksb7F
13. KJ Livak TD Schmittgen 2001 Analysis of relative gene expression data using real-time quantitative pcr and the 2(-delta delta c(t)) method Methods 25 402 408 11846609 10.1006/meth.2001.1262 1:CAS:528:DC%2BD38XhtFelt7s%3D (Pubitemid 34164012)
14. G Williamson C Manach 2005 Bioavailability and bioefficacy of polyphenols in humans. Ii. Review of 93 intervention studies Am J Clin Nutr 81 243S 255S 15640487 1:CAS:528:DC%2BD2MXlvFKltQ%3D%3D
15. MI Davis 2008 Ethanol-bdnf interactions: still more questions than answers Pharmacol Ther 118 36 57 18394710 10.1016/j.pharmthera.2008.01.003 1:CAS:528:DC%2BD1cXlvVSqsbc%3D
16. L Tapia-Arancibia F Rage L Givalois P Dingeon S Arancibia F Beauge 2001 Effects of alcohol on brain-derived neurotrophic factor mrna expression in discrete regions of the rat hippocampus and hypothalamus J Neurosci Res 63 200 208 11169630 10.1002/1097-4547(20010115)63:2<200::AID-JNR1012>3.0.CO;2-Q 1:CAS:528:DC%2BD3MXjslKksA%3D%3D (Pubitemid 32041871)
17. R Miller MA King MB Heaton DW Walker 2002 The effects of chronic ethanol consumption on neurotrophins and their receptors in the rat hippocampus and basal forebrain Brain Res 950 137 147 12231238 10.1016/S0006-8993(02)03014-7 1:CAS:528:DC%2BD38XmvVaisbw%3D (Pubitemid 35264527)
18. H Okamoto T Miki KY Lee T Yokoyama H Kuma H Gu HP Li Y Matsumoto I Yamaoka K Fusumada T Imagawa ZY Wang Y Nakamura Y Takeuchi 2006 Effects of chronic ethanol administration on the expression levels of neurotrophic factors in the rat hippocampus Okajimas Folia Anat Jpn 83 1 6 16862745 10.2535/ofaj.83.1 1:CAS:528:DC%2BD28XotFartLg%3D (Pubitemid 44276615)
19. P Marambaud H Zhao P Davies 2005 Resveratrol promotes clearance of alzheimer's disease amyloid-beta peptides J Biol Chem 280 37377 37382 16162502 10.1074/jbc.M508246200 1:CAS:528:DC%2BD2MXhtF2isr3P (Pubitemid 41642343)
20. Vingtdeux V, Dreses-Werringloer U, Zhao H, Davies P, Marambaud P (2008) Therapeutic potential of resveratrol in alzheimer's disease. BMC Neurosci 9(Suppl 2):S6
21. E Savaskan G Olivieri F Meier E Seifritz A Wirz-Justice F Muller-Spahn 2003 Red wine ingredient resveratrol protects from beta-amyloid neurotoxicity Gerontology 49 380 383 14624067 10.1159/000073766 1:CAS:528:DC%2BD3sXptVWkt7c%3D (Pubitemid 37465118)
22. BL Queen TO Tollefsbol 2010 Polyphenols and aging Curr Aging Sci 3 34 42 20298168 10.2174/1874609811003010034 1:CAS:528:DC%2BC3cXhsVKisLzM
23. A Camins FX Sureda F Junyent E Verdaguer J Folch C Beas-Zarate M Pallas 2010 An overview of investigational antiapoptotic drugs with potential application for the treatment of neurodegenerative disorders Expert Opin Investig Drugs 19 587 604 20402598 10.1517/13543781003781898 1:CAS:528:DC%2BC3cXkvVyju7o%3D
24. AS Darvesh RT Carroll A Bishayee WJ Geldenhuys CJ Van der Schyf 2010 Oxidative stress and alzheimer's disease: dietary polyphenols as potential therapeutic agents Expert Rev Neurother 10 729 745 20420493 10.1586/ern.10.42 1:CAS:528:DC%2BC3cXlsVWlsrk%3D
25. D Wu 2005 Neuroprotection in experimental stroke with targeted neurotrophins NeuroRx 2 120 128 15717063 10.1602/neurorx.2.1.120 (Pubitemid 40128032)
26. GA Ford CA Bryant AA Mangoni SH Jackson 2004 Stroke, dementia, and drug delivery Br J Clin Pharmacol 57 15 26 14678336 10.1046/j.1365-2125.2003.01939.x 1:STN:280:DC%2BD3srps1yisw%3D%3D (Pubitemid 38067946)
27. O Weinreb T Amit O Bar-Am MB Youdim 2007 Induction of neurotrophic factors gdnf and bdnf associated with the mechanism of neurorescue action of rasagiline and ladostigil: new insights and implications for therapy Ann N Y Acad Sci 1122 155 16828 18077571 10.1196/annals.1403.011 1:CAS:528: DC%2BD1cXhtVOksLk%3D (Pubitemid 350249546)
28. G Ochs RD Penn M York R Giess M Beck J Tonn J Haigh E Malta M Traub M Sendtner KV Toyka 2000 A phase i/ii trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis Amyotroph Lateral Scler Other Motor Neuron Disord 1 201 206 11464953 10.1080/14660820050515197 1:CAS:528: DC%2BD3cXmtVaqt7o%3D
29. -(1999) A controlled trial of recombinant methionyl human bdnf in als: the bdnf study group (phase iii). Neurology 52:1427-1433
30. WM Pardridge YS Kang JL Buciak 1994 Transport of human recombinant brain-derived neurotrophic factor (bdnf) through the rat blood-brain barrier in vivo using vector-mediated peptide drug delivery Pharm Res 11 738 746 8058646 10.1023/A:1018940732550 1:CAS:528:DyaK2cXktFOrtrY%3D (Pubitemid 24171772)
31. A Kishino N Katayama Y Ishige Y Yamamoto H Ogo T Tatsuno T Mine H Noguchi C Nakayama 2001 Analysis of effects and pharmacokinetics of subcutaneously administered bdnf Neuroreport 12 1067 1072 11303747 10.1097/00001756-200104170- 00040 1:CAS:528:DC%2BD3MXjtVWgs7Y%3D (Pubitemid 32281476)